Scarica l'app Stockscreener
52.63
5.21%
2.635
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report - Benzinga
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report - Benzinga
Merck Nears Deal to Buy Terns Pharmaceuticals - Bloomberg.com
SLS Vs. TERN: Which Pharma Stock Has More Upside As Merck Eyes $6B Cancer Bet Ahead Of Keytruda Patent Cliff - Stocktwits
Merck nears $6 bln deal for Terns Pharma, FT reports By Investing.com - Investing.com Canada
Merck (MRK) Nears $6 Billion Acquisition of Terns Pharmaceuticals (TERN) - GuruFocus
Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE) - Seeking Alpha
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - marketscreener.com
According to insiders, merger negotiations between Merck (MRK) and Terns Pharmaceuticals, Inc. (TERN) have entered a critical stage. - Bitget
Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports - marketscreener.com
Acorn Capital Sells $5.2M in Terns Pharma Shares, Remains Top Holding | 2026 UpdateNews and Statistics - IndexBox
Terns Pharmaceuticals (NASDAQ:TERN) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Terns Pharmaceuticals (NASDAQ:TERN) Sets New 12-Month HighShould You Buy? - MarketBeat
TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Aug PreEarnings: What is the target price for Terns Pharmaceuticals Inc stockShare Buyback & Stepwise Trade Execution Plans - baoquankhu1.vn
Terns Pharmaceuticals stock hits all-time high at 48.27 USD By Investing.com - Investing.com Australia
Terns Pharmaceuticals stock hits all-time high at 48.27 USD - Investing.com
How Vestal Point’s Big Bet On TERN-701 At Terns Pharmaceuticals (TERN) Has Changed Its Investment Story - Yahoo Finance
Aug Setups: What is the target price for Terns Pharmaceuticals Inc stockWall Street Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Superstring Capital Reduces Terns Pharmaceuticals Holding in Late 2025News and Statistics - IndexBox
Terns Pharmaceuticals CEO Burroughs sells $681k in stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals CEO Burroughs sells $681k in stock - Investing.com
Amy Burroughs Sells 14,583 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat
Terns Pharmaceuticals CEO Amy L. Burroughs Sells Shares - TradingView
Terns Pharmaceuticals (NASDAQ: TERN) CEO sells exercised shares under plan - Stock Titan
Vestal Point Capital's Major Investment in Terns Pharma | 2026News and Statistics - IndexBox
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally - The Globe and Mail
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Terns Pharmaceuticals (TERN) Is Up 8.6% After Pipeline Update And Index Inclusion News - simplywall.st
5,700,000 Shares in Terns Pharmaceuticals, Inc. $TERN Acquired by Commodore Capital LP - MarketBeat
Terns Pharmaceuticals Financial Outlook Raises Concerns Amid Market Trends - timothysykes.com
Integral Health Asset Management LLC Grows Stock Holdings in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
4 Biotech Stocks to Watch for Potential Upside in 2026 - The Globe and Mail
Terns Pharmaceuticals’ Valuation Reassessed Amid Latest Developments - StocksToTrade
Terns Pharmaceuticals (NASDAQ:TERN) Trading 4.8% HigherWhat's Next? - MarketBeat
Terns Pharmaceuticals CEO outlines strategy to advance novel leukemia therapy - Traders Union
Terns Pharmaceuticals shares rise as investors focus on recent presentation, index-addition notice, and upcoming earnings - Quiver Quantitative
Terns Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:TERN) - MarketBeat
Terning The Flight to Innovation with Terns Pharma - TD Securities
TERN: TERN-701 shows best-in-disease efficacy and safety in CML, with pivotal trials and launch funded - TradingView
Dynamic Technology Lab Private Ltd Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
TERN: TERN-701 shows superior efficacy and safety in CML, positioning for major market impact - TradingView
DLD Asset Management LP Cuts Stake in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Will Terns Pharmaceuticals Inc. stock benefit from automation2026 Opening Moves & Safe Entry Momentum Tips - Naître et grandir
Wall Street analysts see a 50.91% upside in Terns Pharmaceuticals (TERN): Can the stock really move this high? - MSN
What is Terns Pharmaceuticals Incs debt to equity ratioWeekly Stock Report & Breakout Confirmation Trade Signals - baoquankhu1.vn
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals - Stocktwits
TERN Earnings History & Surprises | EPS & Revenue Results | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
TERN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: How does Terns Pharmaceuticals Inc score in quality rankingsMarket Rally & Low Risk Entry Point Tips - baoquankhu1.vn
A Look At Terns Pharmaceuticals (TERN) Valuation After Leerink Highlights Early TERN-701 CML Data - Yahoo Finance
Does Rising Hedge Fund Interest in Terns (TERN) Reveal a Deeper Bet on Single-Asset Biotech Risk? - simplywall.st
15 Stocks with the Biggest Hedge Fund Momentum - Insider Monkey
Analyst Optimistic on Terns (TERN) Citing Possible $4.8B Market for Upcoming Leukemia Drug - Yahoo Finance
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):